Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lumora vs Trimi

Lumora
Graded #206

Lower grade

vs+20.30000000000001
Trimi
Graded #7

Higher grade

The verdict

Trimi takes it — 86.4/100 to 66.1/100.

Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTrimi +57
36
93
Dose & formulationTrimi +9
75
84
Clinical oversightLumora +5
87
82
Labs & monitoringTrimi +7
76
83
FulfillmentTrimi +16
74
90
Contract termsTrimi +29
55
84
Lumora · left barTrimi · right bar

The numbers

MetricLumoraTrimi
WeighScore66.1/10086.4/100
GradeCB
Scorecard rank#206#7
Semaglutide$199/mo (starting dose, plus a separate fee, compounded)$129/mo
Tirzepatide$299/mo (starting dose, compounded)$199/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Lumora

Graded #206 · C

Strengths

  • Compounded semaglutide (5 dose tiers) and tirzepatide (6 dose tiers) in injectable and sublingual forms
  • Physician-founded by board-certified Drs. Sean and Shannon Arora (Arora Health & Aesthetics); clinician reviews every assessment
  • LegitScript certified, HIPAA compliant, medications dispensed through licensed U.S. pharmacy partners
  • Visit fees, medication, labs, and follow-up all included; full pricing shown before commitment
  • Peptide therapies offered including NAD+, sermorelin, glutathione, gonadorelin, and PT-141

Where it loses points

  • Pricing is fully gated behind the assessment — no public pricing; actual monthly costs unverifiable without completing intake
  • Compounded medications are not FDA-approved; compounding pharmacy partners not publicly named
  • Newer brand with 2026 founding; no Trustpilot rating or accessible public patient reviews found
  • No dietitian, coaching, or HSA/FSA eligibility disclosed on public pages
  • Claims all 50 states but 'treatment options may vary by state' with no explicit state-by-state coverage list
Trimi

Graded #7 · B

Strengths

  • Low flat pricing on both semaglutide and tirzepatide
  • Both molecules on a single membership
  • Free shipping to all 50 states
  • Fast dispatch once the prescriber signs off

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • Injection only — no oral or sublingual route
  • Dispensing pharmacy not publicly named
  • Shorter public track record than the incumbents

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard